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ROBERT M. GRAHAM, MD, MICHAEL A. FIFER, MD, FACC 
Boston, Massachusetts 
To assess the effect of short-term alteration of left atrial 
pressure and volume on the circulating plasma level of 
atrial natriuretic factor, 11 patients with left atrial hyper-
tension due to mitral stenosis were studied at the time of 
percutaneous balloon mitral valvuloplasty. Hemodynamic 
measurements and plasma atrial natriuretic factor levels 
were obtained before, immediately (5 to 10 min) after and 
24 h after valvuloplasty, arid echocardiographic left atrial 
size was determined before and 24 h after valvuloplasty. 
Immediately after valvuloplasty, left atrial pressure de-
creased from 28 ± 2 to 10 ± 1 mm Hg (p < 0.0005), mitral 
pressure gradient decreased from 20 ± 2 to 7 ± 1 mm Hg (p 
< 0.0005), mitral valve area increased from 0.8 ± 0.1 to 1.9 
± 0.2 cm2 (p < 0.0005) and plasma atrial natriuretic factor 
level rose from 249 ± 42 to 348 ± 50 pg/ml (p < 0.01). This 
short-term rise in atrial natriuretic factor level may reflect a 
transient increase in left atrial pressure associated with 
balloon occlusion of the mitral valve. 
Since the discovery of atrial natriuretic factor and its ana-
tomic localization in the atria (1,2), the factors stimulating 
its release have been under investigation. Plasma level of 
atrial natriuretic factor is elevated in patients with chronic 
right or left atrial hypertension, or both (3-8). In experimen-
tal models, short-term volume loading increases secretion of 
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Twenty-four hours after valvuloplasty, pulmonary cap-
illary wedge pressure was 15 ± 1 mm Hg (p < 0.001 versus 
left atrial pressure before valvuloplasty, p < 0.005 versus 
left atrial pressure immediately after valvuloplasty), left 
atrial volume had decreased to 58 ± 8 from 81 ± 10 cm3 
before valvuloplasty (p < 0.001), left atrial wall tension had 
declined to 24 ± 7 from 48 ± 16 dynes/cm x 103 (p < 0.002) 
and plasma atrial natriuretic factor level had fallen to 98 ± 
16 pg/ml (p < 0.001 versus before valvuloplasty, p < 0.0005 
versus immediately after valvuloplasty). Atrial natriuretic 
factor level correlated with left atrial pressure (r = 0.69, P 
< 0.001), volume (r = 0.67, P < 0.002) and wall tension 
(r = 0.75, P < 0.001). These results indicate that secretion 
of atrial natriuretic factor is sensitive to short-term altera-
tion of left atrial stretch in patients with chronic elevation of 
left atrial pressure. 
(J Am Coli CardioI1988;12:649-55) 
atrial natriuretic factor (9,10); atrial natriuretic factor level 
has been shown to rise in association with short-term eleva-
tion of right (11,12) or left (12,13) atrial pressure. In clinical 
studies, iilcreases in atrial pressure induced by leg rais-
ing (6), exercise (5,14) or infusion of X-ray contrast medium 
(7) brought about a rise in plasma level of atrial natriuretic 
factor. Although secretion of atrial natriuretic factor appears 
to be closely related to left and right atrial volume and 
transmural pressure, the effect of a short-term reduction 
in atrial pressure and volume on atrial natriuretic factor 
secretion in humans has not been studied fully. To assess the 
effect of an isolated reduction in left atrial pressure and 
volume on circulating plasma levels of atrial natriuretic factor, 
we studied 11 patients with left atrial hypertension due to 
mitral stenosis who underwent percutaneous balloon mitral 
valvuloplasty. 
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Methods 
Study patients. Eleven patients (nine women and two 
men) with a mean age of 45 years (range 21 to 69) were 
studied. Two of the patients were in New York Heart 
Association functional class IV, eight in class III and one in 
class II. Eight patients had sinus rhythm and three had atrial 
fibrillation. Three patients had undergone previous surgical 
mitral commissurotomy and had restenosis of the mitral 
valve. One patient had previously undergone aortic valve 
replacement for aortic stenosis. None of the patients had 
significant coronary artery disease, as assessed clinically in 
those patients <40 years of age and by coronary arteriogra-
phy in older patients. Nine patients were taking digoxin, nine 
a diuretic and one a beta-adrenergic blocking agent. The 
protocol was approved by the Subcommittee for Human 
Studies of the Massachusetts General Hospital on December 
16, 19S5; informed consent was obtained from all subjects. 
Percutaneous mitral valvuloplasty. Studies were per-
formed under mild sedation (diazepam, 5 mg orally, and 
diphenhydramine, 25 mg orally, given 1 h before study). 
Right heart catheterization was performed through the right 
internal jugular vein with a 7F Swan-Ganz thermodilution 
catheter. Systemic arterial pressure was monitored by 
means of an IS-gauge Teflon catheter placed in the left radial 
artery. Transseptalleft heart catheterization was performed 
through the right femoral vein with an SF Mullins trans septal 
sheath and dilator (USCI) and a modified Brockenbrough 
needle. Heparin, 10,000 U, was administered intravenously 
after the trans septal puncture. The interatrial septum was 
dilated with an S mm balloon dilation catheter to allow 
passage of larger valvuloplasty balloon catheters. Mitral 
valvuloplasty was performed with IS, 20 and 25 mm balloon 
dilation catheters (Mansfield), alone or in combination (six 
patients), as previously described (15). Inflation-deflation 
time was approximately 15 s. Multiple balloon inflations 
were performed. 
Hemodynamic data. Right atrial and pulmonary artery 
pressures were measured from the Swan-Ganz catheter, left 
atrial pressure from the trans septal sheath and left ventric-
ular pressure from a 7F end-hole balloon catheter placed into 
the left ventricle by way of the trans septal sheath. Measure-
ments were made before the first balloon inflation and 5 to 10 
min after the final balloon inflation. Thermodilution cardiac 
output was measured simultaneously, and mitral valve area 
was calculated from the Gorlin formula (16). Right atrial 
pressure, left atrial pressure as estimated from the pulmo-
nary artery wedge pressure and pulmonary artery pressure 
were again obtained 24 h after valvuloplasty. 
Echocardiographic data. Two-dimensional echocardiog-
raphy was performed before and 24 h after mitral valvulo-
plasty with the use of an ATL Mark 600 with a 3 MHz 
transducer. Parasternal short-axis views at the level of the 
aortic valve and apical four chamber views were obtained to 
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visualize the left and right atria. Atrial volume (V) was 
calculated from an ellipsoid formula: 
4 DI D2 D3 V =-7T- --
3 2 2 2 
where DI is long-axis length in the apical four chamber view 
and D2 and D3 are mediolateral and anteroposterior dimen-
sions, respectively, in the parasternal short-axis view. Tech-
nically adequate echocardiograms were obtained in 10 of the 
11 patients. 
For calculation of atrial wall tension, the atria were 
assumed to be spherical, and average radius (R) was calcu-
lated from atrial volume: 
R=",3/W. V 4;' 
Tension (T) was then calculated from the Laplace relation: 
T = 1,333 PRl2, 
where P is atrial pressure and 1,333 is the constant for 
conversion from millimeters of mercury to dynes/cm2. 
Atrial natriuretic factor, renin and aldosterone. Paired 
blood samples, 6 ml, were drawn from the pulmonary artery 
at baseline, i.e., after trans septal puncture and before bal-
loon dilation, 5 to 10 min after final balloon dilation and 24 h 
after mitral valvuloplasty. Samples were drawn into plastic 
syringes and immediately transferred to siliconized glass 
tubes containing 0.1 ml ethylenediaminetetraacetic acid and 
placed on ice. Samples were then centrifuged at 4°C and the 
plasma separated and stored at -70°C. Extraction of atrial 
natriuretic factor (ANF) was performed by passing plasma (2 
ml) over an activated C IS cartridge (Sep-Pak). For assay, 
100 ILl of extract and 300 ILl of buffer were preincubated (16 
h at 4°C) with 100 ILl of antihuman ANF (99-126) antiserum 
(Peninsula Labs), which had been diluted in 1% (vol/vol) 
Triton X-100 to yield 30 to 40% binding of 10,000 counts/min 
ofe25IJ-labeled rat ANF (103-126). This antiserum has 100% 
cross-reactivity with rat ANF (103-126) as well as human 
ANF (99-126). Recovery, monitored by adding tracer 
amounts of [1251] ANF (103-126), was SO ± 5%. Plasma atrial 
natriuretic factor values were corrected for the recovery. 
Sensitivity of the assay was 2 pg/tube (95% confidence 
limits), and inter- and intraassay variability was 9.2 and 
6.1 %, respectively. The standard curve was linear up to 
1,500 pg/ml, with a half-maximal displacement of tracer-
binding at 140 pg/ml. In all assays, the concentration of rat 
ANF (103-126) used in constructing the standard curves was 
confirmed by initial amino acid analysis. The normal value in 
our laboratory is 19 ± 4 pg/ml. 
Plasma renin activity and aldosterone concentration in 
blood samples drawn before and 24 h after valvuloplasty 
were determined in eight patients by radioimmunoassay, as 
previously described (17). All samples were handled in 
blinded fashion. 
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Table 1. Hemodynamic, Echocardiographic and Endocrine Effects of Mitral Valvoplasty in 11 Patients 
Patient 
1 Pre 
5 to 10 min 
24 h 
2 Pre 
5 to 10 min 
24 h 
3 Pre 
5 to 10 min 
24 h 
4 Pre 
5 to 10 min 
24 h 
5 Pre 
5 to 10 min 
24 h 
6 Pre 
5 to 10 min 
24 h 
7 Pre 
5 to 10 min 
24 h 
8 Pre 
5 to 10 min 
24 h 
9 Pre 
5 to 10 min 
24 h 
10 Pre 
5 to 10 min 
24 h 
11 Pre 
5 to 10 min 
24 h 
RAP PAP LA/PCWP MVV' 
(mm Hg) (mm Hg) (mm Hg) (mm Hg) 
5 75 38 30 
2 35 12 6 
8 36 16 
10 40 32 28 
.25 18 14 
10 33 16 
40 30 25 
25 7 
21 13 
4 42 30 24 
18 8 4 
6 13 10 
3 40 32 20 
8 28 14 7 
9 22 16 
2 50 20 9 
o 40 12 8 
9 40 23 
5 
2 
o 
8 
9 
2 
14 
2 
6 
45 
35 
26 
35 
20 
27 
36 
25 
28 
32 
17 
44 
62 
20 
21 
18 
12 
10 
22 
6 
12 
25 
5 
16 
21 
12 
19 
35 
12 
5 
15 
3 
25 
16 
12 
20 
3 
n 9 11 
11 
11 11 
Mean ± SEM 
Pre 3 ± 1 45 ± 4 28 ± 2 20 ± 2 
CO 
(Umin) 
4.5 
5.6 
6.0 
5.2 
6.4 
5.2 
4.1 
5.9 
4.7 
6.0 
2.9 
2.9 
3.2 
3.7 
2.7 
3.6 
4.4 
5.6 
5.4 
5.5 
503 
4.1 
0.7 
2.0 
1.J 
\.3 
1.0 
203 
0.7 
2.8 
0.8 
2.1 
0.7 
0.8 
0.6 
1.5 
0.6 
1.8 
0.6 
2.1 
1.4 
1.6 
\.3 
2.8 
11 11 
4.5 ± 0.4 0.9 ± 0.1 
5 to 10 m 
24 h 
2 ± I 26 ± 2* 10 ± 1* 7 ± 1* 4.8 ± OJ 1.9 ± 0.2* 
8 ± l*t 28 ± 3* 15 ± I *:j: 
38 
30 
28 
33 
18 
30 
24 
22 
32 
27 
45 
53 
62 
62 
40 
23 
54 
41 
107 
\06 
163 
99 
72 
68 
62 
36 
87 
60 
72 
40 
52 
33 
64 
49 
57 
34 
75 
67 
101 
95 
JO 10 
45 ± 8 81 ± JO 
43 ± 8 58 ± 8* 
RAT LAT 
(dynes.W) (dynes.W) 
7 86 
10 31 
o 55 
13 27 
49 
18 
5 55 
7 16 
4 55 
II 23 
3 31 
14 31 
8 
12 
18 
27 
8 
6 ± 2 
13 ± 2* 
30 
15 
35 
16 
44 
27 
40 
36 
10 
48 ± 5 
24 ± 2* 
ANF 
(pg/ml) 
464 
432 
169 
354 
460 
191 
314 
588 
68 
311 
510 
73 
79 
227 
133 
102 
112 
52 
52 
51 
68 
343 
434 
38 
121 
305 
103 
346 
302 
138 
255 
388 
42 
II 
249 ± 41 
346 ± 50* 
98 ± 16*t 
*p < 0.01 vs. prevalvuloplasty; tp < 0.01; :j:p < 0.05 vs. 5 to 10 min postvuloplasty Values shown are mean ± SEM. ANF = plasma level of atrial natriuretic 
factor; CO = cardiac output; LAlPCWP = left atrial or pulmonary capillary wedge pressure; LAT = left atrial wall tension; LA V = left atrial volume; MVA = 
mitral valve area; MVV' = mean mitral valve gradient; PAP = mean pulmonary artery pressure; Pre = baseline before valvuloplasty; RAP = right atrial pressure; 
RAT = right atrial wall tension; RA V = right atrial volume; 5 to 10 min = 5 to 10 min after valvuloplasty; 24 h = 24 h after valvuloplasty. 
Statistical analysis. Values are expressed as mean ± 
SEM, Data for which two sets of measurements were made 
were compared with the paired Student's t test. For results 
where three separate measurements were made over time, 
comparisons were made by analysis of variance; compari-
sons of group means were made with the use of the Neuman-
Keuls test (18). Differences between groups were considered 
significant if p < 0.05. Regression analyses were performed 
with the use of a linear least squares method. 
Results 
Hemodynamic results of mitral valvuloplasty. Heart rate 
was similar before (92 ± 4 beats/min) and immediately after 
(91 ± 5 beats/min) valvuloplasty, but decreased at 24 h (76 ± 
4 beats/min, p < 0.01 versus pre- and immediately postval-
vuloplasty). Systolic arterial pressure was not significantly 
affected by the procedure. The changes in other hemody-
namic variables resulting from balloon mitral valvuloplasty 
are shown in Table 1 and Figure 1. 
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ANF 
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* p < ,01 vs PRE PMV 
* 
5-lOmin 24hrs 
POST POST 
PMV PMV 
t p < ,01 vs 5-10min POST PMV 
Figure 1. Left atrial (LA) or pulmonary capillary wedge (PCW) 
pressure, left atrial volume and plasma level of atrial natriuretic 
factor (ANF) before, 5 to 10 min after and 24 h after percutaneous 
balloon mitral valvuloplasty (PMV) , Mean values ± SEM are 
shown, Atrial natriuretic factor level was increased 5 to 10 min after 
percutaneous balloon mitral valvuloplasty, at a time when left atrial 
pressure had decreased, At 24 h, pulmonary capillary wedge pres-
sure and left atrial volume had declined, as had the atrial natriuretic 
factor leveL 
Left atrial pressure was markedly elevated before valvu-
loplasty at 28 ± 2 mm Hg and decreased immediately after 
valvuloplasty to 10 ± 1 mm Hg (p < 0,0005), Mean mitral 
valve gradient was reduced from 20 ± 2 to 7 ± 1 mm Hg (p 
< 0.0005). Cardiac output did not change significantly. 
Calculated mitral valve area increased from 0.8 ± 0.1 to 1.9 
± 0.2 cm2 (p < 0.0005); there was variation in the degree of 
improvement. Twenty-four hours after valvuloplasty, pul-
600 ANF vs LAP 600 
r =.69 
p<.OOl 0 
E 400 400 
.... CD 0 co !3 ~ 
... 
0 
z 200 200 
« 
0 
0 0 
0 10 20 30 40 
LAP (mm H9) 
0 
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monary capillary wedge pressure was 15 ± 1 mm Hg, 
somewhat greater than the left atrial pressure immediately 
after valvuloplasty (p < 0.005), but considerably lower than 
the initial left atrial pressure (p < 0.001). Right atrial 
pressure increased 24 h after the procedure. No patient had 
a significant left to right shunt, as judged by oximetry, after 
valvuloplasty. 
Atrial volume and wall tension (Table 1, Fig. 1). Left atrial 
volume decreased from 81 ± 10 to 58 ± 8 cm3 after mitral 
valvuloplasty (p < 0.001). Right atrial volume was not 
affected by valvuloplasty. Left atrial wall tension decreased 
by 50% after valvuloplasty (48 ± 16 to 24 ± 7 dynes cm x 
103 , P < 0.002) and right atrial wall tension increased. 
Atrial natriuretic factor, renin and aldosterone. Baseline 
atrial natriuretic factor level was markedly elevated at 249 ± 
42 pg/ml. Five to 10 min after final balloon inflation, atrial 
natriuretic factor level had increased to 348 ± 50 pg/ml (p < 
0.01). Twenty-four hours after valvuloplasty, atrial natri-
uretic factor level had fallen to 98 ± 16 pg/ml (p < 0.001 
versus baseline, p < 0.0005 versus immediately after valvu-
loplasty). There was no significant change in plasma renin 
activity (9 ± 2 before versus 12 ± 4 ng/ml per h 24 h after 
valvuloplasty) or aldosterone concentration (217 ± 49 before 
versus 153 ± 28 pg/ml 24 h after valvuloplasty). 
Relation of atrial natriuretic factor level to atrial pressure, 
volume and wall tension (Fig. 2). Plasma concentration of 
atrial natriuretic factor correlated with left atrial pressure 
(r = 0.69, p < 0.001), volume (r = 0.67, p < 0.002) and wall 
tension (r = 0.75, p < 0.001). There was no significant 
correlation between atrial natriuretic factor level and right 
atrial pressure, volume or wall tension. 
Figure 2. Correlations between plasma level of atrial natriuretic 
factor (ANF) and left atrial pressure (LAP), volume (LA V) and wall 
tension. Significant correlations were found between atrial natri-
uretic factor plasma level and each of the variables of left atrial 
distension. PMV = percutaneous balloon mitral valvuloplasty. 
ANF vs LAV 600 ANF vs LA TENSION 
400 
o 0 0 00 0 0 0 00 
• • 
r = .67 200 r = .75 
• 0 • p <.002 p<.OOl .~~ 0 
0 
40 80 120 160 0 20 40 60 80 100 
LAV (cm3) TENSION (dynes/em. 103) 
0 PRE PMV 
• 24 HRS POST PMV 
JACC Vol. 12, No.3 
September 1988:649-55 
Discussion 
Previous studies. Atrial natriuretic factor is a peptide 
hormone synthesized in, stored in and released from mam-
malian cardiac atria. Radioimmunoassay has confirmed the 
presence of atrial natriuretic factor in human plasma (19,20). 
Its concentration is higher in blood from the right atrium and 
ventricle than in blood from the venae cavae (9,21), indicat-
ing that atrial natriuretic factor enters the circulation on the 
right side of the heart. Atrial natriuretic factor level in 
coronary sinus blood is much higher than in right heart blood 
(7,13,20,22), indicating that atrial natriuretic factor is se-
creted by way of the coronary sinus into the right atrium 
from left or right atrial myocytes, or both. A decline in atrial 
natriuretic factor concentration has been demonstrated be-
tween the pulmonary artery and vein (23). An increase 
occurs across the left side of the heart (5,6), indicating 
Thebesian vein drainage from the left atrium. Although both 
atria appear to secrete atrial natriuretic factor, the relative 
contributions of the left and right atria to the plasma level of 
atrial natriuretic factor are unknown. 
Characterization of the stimulus of atrial natriuretic 
factor secretion has been the subject of several studies. 
Plasma level of atrial natriuretic factor is elevated in condi-
tions associated with elevation of atrial pressures, including 
congestive heart failure (3-6,24) and paroxysmal atrial 
tachycardia (25). Recently, atrial natriuretic factor level has 
been shown to be elevated in mitral stenosis (8). Short-term 
increases in left or right atrial pressure have been shown to 
be associated with increases in atrial natriuretic factor level 
in animal models (11-13) and in humans (5-7,14). Ledsome 
et al. (13) inflated left atrial balloons in anesthetized dogs to 
produce short-term partial obstruction of the mitral valve 
and showed that the resulting increase in atrial pressure was 
associated with an increase in plasma concentration of atrial 
natriuretic factor. Change in plasma atrial natriuretic factor 
level after reduction in chronically elevated atrial pressure 
has not been fully studied. 
Relation of plasma atrial natriuretic factor to left atrial 
pressure, volume and tension. Our study was designed, 
therefore, to determine the effect of short-term reversal of 
left atrial hypertension on the plasma level of atrial natri-
uretic factor. Elevation of baseline atrial natriuretic factor 
level in our study patients presumably reflected the elevated 
left atrial pressure because right atrial pressure was normal 
or minimally elevated. Because right atrial pressure actually 
increased 24 h after valvuloplasty (possibly related to liber-
alization of fluid intake or as a result of the decrease in 
plasma atrial natriuretic factor), we conclude that the reduc-
tion in atrial natriuretic factor level at 24 h after valvulo-
plasty was also related to left atrial hemodynamics. 
The reduction in atrial natriuretic factor level 24 h after 
valvuloplasty was also associated with a decrease in left 
atrial volume, as assessed by echocardiography. Similarly, 
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Hollister et al. (26), in a preliminary report, found that 
plasma atrial natriuretic factor concentration correlated with 
right atrial volume in patients subjected to head-up and 
head-down tilt. Absolute atrial pressure and plasma atrial 
natriuretic factor level may be dissociated in pericardial 
tamponade because transmural pressure (and presumably 
atrial volume) is low in this condition (27). To our knowl-
edge, our study is the first to demonstrate a significant 
correlation between left atrial volume and plasma level of 
atrial natriuretic factor. We also found a significant correla-
tion between calculated left atrial wall tension and plasma 
atrial natriuretic factor concentration, thus extending to the 
left atrium in humans the findings of Schiebinger and Linden 
(28) in the isolated rat left atrium and the preliminary results 
of Hollister et al. (26) for the right atrium in humans. 
The increase in plasma atrial natriuretic factor level 5 to 
10 min after valvuloplasty, at a time when left atrial pressure 
had decreased, was an unexpected finding. We postulate that 
this short-term increase in atrial natriuretic factor level was 
a reflection of transient (unmeasured) elevation of left atrial 
pressure during the preceding balloon occlusion of the mitral 
valve. This hypothesis is supported by the study of Ledsome 
et al. (13), in which balloon occlusion of the mitral valve 
resulted in increases in left atrial pressure and plasma atrial 
natriuretic factor level within 2 min (13). After deflation of 
the balloon, left atrial pressure returned to baseline immedi-
ately, but plasma level of atrial natriuretic factor lagged 
behind, returning to baseline in exponential fashion with a 
half-time of 4.5 min. Gunther et al. (22), in a preliminary 
report, found that coronary sinus atrial natriuretic factor 
level rose within 30 s of the initiation of simultaneous 
atrioventricular pacing in humans and fell exponentially after 
cessation of pacing with a half-time of 6 min. The immediate 
rise in plasma atrial natriuretic factor level and the fall at 24 
h in our subjects indicate that long-term elevation of left 
atrial pressure and plasma atrial natriuretic factor concen-
tration does not preclude short-term responsiveness of atrial 
natriuretic factor secretion to either increases or decreases 
in left atrial pressure. 
Limitations of the study. Despite reports of an inhibitory 
effect of atrial natriuretic factor on secretion of renin (29) and 
aldosterone (30), an increase in levels of these hormones in 
association with the fall in atrial natriuretic factor level at 24 
h was not demonstrated in our study. We did not attempt to 
measure either renal or hemodynamic variables that are 
influenced by atrial natriuretic factor (31), because any effect 
of the change in concentration would likely be obscured by 
the effects of changes in volume status associated with the 
valvuloplasty procedure, X-ray contrast medium and ame-
lioration of the degree of mitral stenosis. Thus, the study was 
not designed to determine whether a reduction of a patho-
logically elevated atrial natriuretic factor level is associated 
with measurable changes in renal function or hemodynam-
ics. Similarly, our study does not address the question of 
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whether a reduction of left atrial pressure intrinsically is 
associated with changes in renal function that are indepen-
dent of the effects of atrial natriuretic factor (32). 
Second, baseline atrial natriuretic factor level was mea-
sured after puncture and dilation of the interatrial septum. To 
evaluate the possibility that plasma level of atrial natriuretic 
factor was affected by mechanical trauma to the septum, we 
measured levels before transseptal puncture, approximately 3 
min after puncture and passage of the trans septal sheath apd / 
approximately 3 min after dilation of the septum in six 
additional patients undergoing percutaneous mitral valvulo-
plasty. There were no significant differences in atrial natri-
uretic factor level among the three time periods. 
Third, we measured atrial natriuretic factor levels in 
pulmonary artery blood samples only. Pulmonary artery 
atrial natriuretic factor level would be expected to reflect 
secretion of the hormone from the left atrium by way of the 
coronary sinus but not by way of the Thebesian circulation. 
Whereas systemic arterial atrial natriuretic factor level 
would reflect direct secretion into the left atrial chamber, the 
influence of its secretion by way of the coronary sinus could 
have been attenuated by pulmonary metabolism of atrial 
natriuretic factor (23). 
Fourth, the use of pulmonary capillary wedge pressure as 
an estimate of left atrial pressure is a potential source of 
error (33). We were unable to measure left atrial pressure 24 
h after valvuloplasty because it would have been unethical to 
leave the left atrial sheath in place for that period. 
Finally, the immediate rise in atrial natriuretic factor 
level was unanticipated at the time of study design. For this 
reason, we did not obtain left atrial (or pulmonary capillary 
wedge) pressure during balloon occlusion of the mitral valve. 
Similarly, we did not obtain serial samples for measurement 
of atrial natriuretic factor level during the first 5 min after 
balloon inflation. These data would test our hypothesis that 
the early rise in atrial natriuretic factor level was associated 
with a transient increase in left atrial pressure. 
Conclusions. Our study demonstrates that atrial natri-
uretic factor level is elevated in patients with chronic left 
atrial hypertension and normal or minimally elevated right 
atrial pressure. Short-term decompression of the left atrium 
by mitral valvuloplasty was followed within 24 h by a 
marked fall in plasma atrial natriuretic factor level. Atrial 
natriuretic factor level correlated with left atrial pressure, 
volume and wall tension. These data indicate that left atrial 
stretch is an important determinant of atrial natriuretic factor 
secretion in humans and that sensitivity of such secretion to 
atrial stretch is maintained over a wide range of left atrial 
pressure. 
We thank Robert Gaivin for expert technical assistance; Paul N. Casale, MD 
and Robert B. Roth, MD for obtaining blood samples and John B. Newell for 
valuable advice regarding statistical methods. 
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